{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:25Z","timestamp":1786986865694,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clinimag.2020.04.021","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:47:03Z","timestamp":1587556023000},"page":"65-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Update on Hodgkin lymphoma from a radiologist's perspective"],"prefix":"10.1016","volume":"65","author":[{"given":"Isaac","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kalisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree Harsha","family":"Tirumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil H.","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Alessandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9844","key":"10.1016\/j.clinimag.2020.04.021_bb0005","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)60035-X","article-title":"Hodgkin\u2019s lymphoma in adults","volume":"380","author":"Townsend","year":"2012","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.clinimag.2020.04.021_bb0010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0015","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2015.07.005","article-title":"Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0020","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang","year":"2019","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.clinimag.2020.04.021_bb0030","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13244-019-0705-y","article-title":"Multimodality imaging of indolent B cell lymphoma from diagnosis to transformation: what every radiologist should know","volume":"10","author":"Alessandrino","year":"2019","journal-title":"Insights Imaging"},{"issue":"27","key":"10.1016\/j.clinimag.2020.04.021_bb0040","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0045","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting [published correction appears in J Clin Oncol 1990 Sep;8(9):1602]","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clinimag.2020.04.021_bb0050","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the first international workshop on interim-PET-scan in lymphoma","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"25","key":"10.1016\/j.clinimag.2020.04.021_bb0055","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0060","author":"National Comprehensive Cancer Network"},{"issue":"12","key":"10.1016\/j.clinimag.2020.04.021_bb0065","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","article-title":"PET-CT for staging and early response: results from the response-adapted therapy in advanced Hodgkin lymphoma study","volume":"127","author":"Barrington","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2014-09-551556","article-title":"How I treat advanced classical Hodgkin lymphoma","volume":"125","author":"Johnson","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/rg.301095088","article-title":"FDG PET\/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease","volume":"30","author":"Paes","year":"2010","journal-title":"Radiographics"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0080","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00247-019-04529-8","article-title":"Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma","volume":"49","author":"McCarten","year":"2019","journal-title":"Pediatr Radiol"},{"issue":"5","key":"10.1016\/j.clinimag.2020.04.021_bb0085","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1148\/rg.275065157","article-title":"Multimodality imaging of Hodgkin disease and non-Hodgkin lymphomas in children","volume":"27","author":"Toma","year":"2007","journal-title":"Radiographics"},{"issue":"8","key":"10.1016\/j.clinimag.2020.04.021_bb0090","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/10428190410001673409","article-title":"Intracranial presentation of systemic Hodgkin\u2019s disease","volume":"45","author":"Hirmiz","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1148\/radiographics.21.1.g01ja02161","article-title":"Extranodal Hodgkin disease: spectrum of disease","volume":"21","author":"Guermazi","year":"2001","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.clinimag.2020.04.021_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13244-015-0407-z","article-title":"Beyond PET\/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications","volume":"6","author":"Keraliya","year":"2015","journal-title":"Insights Imaging"},{"issue":"27","key":"10.1016\/j.clinimag.2020.04.021_bb0105","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group [published correction appears in J Clin Oncol. 2016 Jul 20;34(21):2562]","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0110","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2012.42.4036","article-title":"Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography staged treatment-naive patients with Hodgkin lymphoma","volume":"30","author":"El-Galaly","year":"2012","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.clinimag.2020.04.021_bb0115","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","article-title":"Refinement of the Lugano classification lymphoma response criteria in the era of immunomodulatory therapy","volume":"128","author":"Cheson","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clinimag.2020.04.021_bb0120","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","article-title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","volume":"28","author":"Younes","year":"2017","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clinimag.2020.04.021_bb0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra050276","article-title":"Positron-emission tomography and assessment of cancer therapy","volume":"354","author":"Juweid","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clinimag.2020.04.021_bb0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiol.2015142088","article-title":"Imaging for staging and response assessment in lymphoma","volume":"276","author":"Johnson","year":"2015","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.clinimag.2020.04.021_bb0135","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1182\/blood-2008-06-155820","article-title":"Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma","volume":"112","author":"Kobe","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0140","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ejrad.2016.08.011","article-title":"Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: systematic review and meta-analysis","volume":"85","author":"Adams","year":"2016","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2020.04.021_bb0145","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/annonc\/mdq549","article-title":"End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin\u2019s lymphoma","volume":"22","author":"Barnes","year":"2011","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.clinimag.2020.04.021_bb0150","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","article-title":"Role of functional imaging in the management of lymphoma","volume":"29","author":"Cheson","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0155","first-page":"CD012643","article-title":"Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies","volume":"9","author":"Aldin","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0160","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1200\/JCO.2008.16.0861","article-title":"Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin\u2019s lymphoma and diffuse large B-cell lymphoma: a systematic review","volume":"27","author":"Terasawa","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clinimag.2020.04.021_bb0165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/cncr.27873","article-title":"ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma","volume":"119","author":"Hartridge-Lambert","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0170","unstructured":"La Casce A. Treatment of relapsed or refractory classic Hodgkin lymphoma. In: UpToDate, Larson RA (Ed), UpToDate, Waltham, MA. [Accessed on March 22, 2020]."},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.semnuclmed.2017.09.003","article-title":"PET\/CT for lymphoma post-therapy response assessment in Hodgkin lymphoma and diffuse large B-cell lymphoma","volume":"48","author":"Kobe","year":"2018","journal-title":"Semin Nucl Med"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0180","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.crad.2009.04.006","article-title":"Imaging the lungs in patients treated for lymphoma","volume":"64","author":"Vargas","year":"2009","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2020.04.021_bb0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/028418518502600411","article-title":"Lymph node calcification in malignant lymphoma. Presentation of nine cases and a review of the literature","volume":"26","author":"Strijk","year":"1985","journal-title":"Acta Radiol Diagn (Stockh)"},{"issue":"2","key":"10.1016\/j.clinimag.2020.04.021_bb0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/rg.262045213","article-title":"The thymus: a comprehensive review","volume":"26","author":"Nishino","year":"2006","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.clinimag.2020.04.021_bb0195","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1742-1241.2006.00950.x","article-title":"Rebound thymic enlargement on CT in adults","volume":"61","author":"Yarom","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.clinimag.2020.04.021_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pedneo.2016.02.007","article-title":"Rebound thymic hyperplasia after chemotherapy in children with lymphoma","volume":"58","author":"Chen","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0205","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2214\/ajr.149.2.269","article-title":"Thymic atrophy and regrowth in response to chemotherapy: CT evaluation","volume":"149","author":"Choyke","year":"1987","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.clinimag.2020.04.021_bb0210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/ejcts\/ezu303","article-title":"Reactive thymic hyperplasia following chemotherapy for children with lymphoma: computed tomography may be able to provide valuable information to avoid over-treatment","volume":"47","author":"Tian","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"issue":"Suppl. 4","key":"10.1016\/j.clinimag.2020.04.021_bb0215","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","article-title":"Hodgkin lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Eichenauer","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.clinimag.2020.04.021_bb0220","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the childhood cancer survivor study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clinimag.2020.04.021_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/bjc.2012.228","article-title":"Long-term survival after treatment for Hodgkin\u2019s disease (1973\u20132002): improved survival with successive 10-year cohorts","volume":"107","author":"Bessell","year":"2012","journal-title":"Br J Cancer"},{"issue":"24","key":"10.1016\/j.clinimag.2020.04.021_bb0230","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian-Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0235","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1111961","article-title":"ABVD alone versus radiation-based therapy in limited-stage Hodgkin\u2019s lymphoma","volume":"366","author":"Meyer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0240","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2013.51.9298","article-title":"Omitting radiotherapy in early positron emission tomography-negative stage I\/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"32","author":"Raemaekers","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2020.04.021_bb0245","doi-asserted-by":"crossref","first-page":"440","DOI":"10.6004\/jnccn.2003.0038","article-title":"Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials","volume":"1","author":"Dale","year":"2003","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0250","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1148\/rg.275065189","article-title":"Imaging features of invasive and noninvasive fungal sinusitis: a review","volume":"27","author":"Aribandi","year":"2007","journal-title":"Radiographics"},{"issue":"8","key":"10.1016\/j.clinimag.2020.04.021_bb0255","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3174\/ajnr.A4298","article-title":"Acute invasive fungal rhinosinusitis: a comprehensive update of CT findings and design of an effective diagnostic imaging model","volume":"36","author":"Middlebrooks","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.clinimag.2020.04.021_bb0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1017","key":"10.1016\/j.clinimag.2020.04.021_bb0265","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1259\/bjr\/54532316","article-title":"The reversed halo sign: update and differential diagnosis","volume":"85","author":"Godoy","year":"2012","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2020.04.021_bb0270","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1148\/radiol.2263011932","article-title":"Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT","volume":"226","author":"Kirkpatrick","year":"2003","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.clinimag.2020.04.021_bb0275","first-page":"4147","article-title":"Gemcitabine-induced pulmonary toxicity","volume":"32","author":"Chi","year":"2012","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiol.10092129","article-title":"CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity","volume":"258","author":"Torrisi","year":"2011","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.clinimag.2020.04.021_bb0285","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2214\/AJR.13.11967","article-title":"Vascular toxicity associated with chemotherapy and molecular targeted therapy: what should a radiologist know?","volume":"203","author":"Rohatgi","year":"2014","journal-title":"AJR"},{"issue":"2","key":"10.1016\/j.clinimag.2020.04.021_bb0290","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1634\/theoncologist.6-2-162","article-title":"Hepatotoxicity of chemotherapy","volume":"6","author":"King","year":"2001","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.clinimag.2020.04.021_bb0295","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.mcg.0000173929.60115.b4","article-title":"Drug-induced pancreatitis: an update","volume":"39","author":"Trivedi","year":"2005","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinimag.2020.04.021_bb0300","doi-asserted-by":"crossref","first-page":"281e91","DOI":"10.1034\/j.1600-0609.2000.9r200.x","article-title":"Veno-occlusive disease of the liver after hemopoietic cell transplantation","volume":"64","author":"Carreras","year":"2000","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.clinimag.2020.04.021_bb0305","doi-asserted-by":"crossref","first-page":"60e6","DOI":"10.1097\/00007890-200207150-00011","article-title":"Prognostic value of Doppler ultrasonography in hepatic veno-occlusive disease","volume":"74","author":"Lassau","year":"2002","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.clinimag.2020.04.021_bb0310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.crad.2017.04.003","article-title":"Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors","volume":"72","author":"Alessandrino","year":"2017","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.clinimag.2020.04.021_bb0315","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/rg.252045037","article-title":"Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation","volume":"25","author":"Coy","year":"2005","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.clinimag.2020.04.021_bb0320","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1148\/rg.2018170139","article-title":"Brain imaging findings and neurologic complications after allogenic hematopoietic stem cell transplantation in children","volume":"38","author":"Bonardi","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0325","author":"U. S. Food and Drug Administration\/Center for Drug Evaluation and Research"},{"issue":"4","key":"10.1016\/j.clinimag.2020.04.021_bb0330","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/mabs.20230","article-title":"Brentuximab vedotin","volume":"4","author":"Van de Donk","year":"2012","journal-title":"MAbs"},{"issue":"4","key":"10.1016\/j.clinimag.2020.04.021_bb0335","doi-asserted-by":"crossref","first-page":"S439A","DOI":"10.1016\/j.chest.2018.08.400","article-title":"Brentuximab-induced pneumonitis and acute respiratory failure","volume":"154","author":"Alkhayat","year":"2018","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.clinimag.2020.04.021_bb0340","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/cncr.28712","article-title":"Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the southern network on adverse reactions (SONAR) project","volume":"120","author":"Carson","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0345","author":"U. S. Food and Drug Administration\/Center for Drug Evaluation and Research"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0350","author":"U. S. Food and Drug Administration\/Center for Drug Evaluation and Research"},{"issue":"11","key":"10.1016\/j.clinimag.2020.04.021_bb0355","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.1790","article-title":"Interactions between programmed death-1 and programmed death ligand-1 promote tolerance by blocking the T cell receptor-induced stop signal","volume":"10","author":"Fife","year":"2009","journal-title":"Nat Immunol"},{"issue":"23","key":"10.1016\/j.clinimag.2020.04.021_bb0360","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.clinimag.2020.04.021_bb0365","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","volume":"36","author":"Armand","year":"2018","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.clinimag.2020.04.021_bb0370","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase II study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.clinimag.2020.04.021_bb0375","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"Wolchok","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.clinimag.2020.04.021_bb0380","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clinimag.2020.04.021_bb0385","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00261-019-01935-2","article-title":"Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor","volume":"44","author":"Alessandrino","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2018.03.006","article-title":"Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1","volume":"96","author":"Mekki","year":"2018","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clinimag.2020.04.021_bb0395","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10637-013-9939-6","article-title":"Ipilimumab associated hepatitis: imaging and clinicopathologic findings","volume":"31","author":"Kim","year":"2013","journal-title":"Invest New Drugs"},{"issue":"24","key":"10.1016\/j.clinimag.2020.04.021_bb0405","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1158\/1078-0432.CCR-16-1320","article-title":"PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course","volume":"22","author":"Nishino","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinimag.2020.04.021_bb0410","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clinimag.2017.12.014","article-title":"Multimodality imaging of endocrine immune related adverse events: a primer for radiologists","volume":"50","author":"Alessandrino","year":"2018","journal-title":"Clin Imaging"},{"issue":"2","key":"10.1016\/j.clinimag.2020.04.021_bb0415","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1148\/radiol.2018180572","article-title":"Pembrolizumab-induced sarcoid-like reactions during treatment of metastatic melanoma","volume":"289","author":"Cheshire","year":"2018","journal-title":"Radiology"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712030125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712030125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:42:04Z","timestamp":1760269324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089970712030125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":82,"alternative-id":["S089970712030125X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2020.04.021","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Hodgkin lymphoma from a radiologist's perspective","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2020.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}